The State of Technology Transfer in the Biden Administration

The State of Technology Transfer in the Biden Administration

View Session Speakers

The Bayh-Dole Act is at the heart of technology transfer in America. The Bayh-Dole Act has empowered universities, small businesses, and nonprofits that have received federal grants to retain ownership of any patented inventions — and license those patents to private firms, who then turn promising ideas into real-life products that improve peoples’ lives.

The public-private sector collaboration bolstered by the Bayh-Dole Act has facilitated the creation of more than 480,000 inventions and 15,000 start-ups, while supporting nearly six million new jobs. Before Bayh-Dole, not a single new drug had been developed from NIH-funded inventions when the government took patent rights away from their creators. Since its enactment, approximately 300 new drugs and vaccines are now protecting public health world-wide.

Still, year after year the Bayh-Dole Act comes under assault from those who would like to turn back the clock. And federal laboratories have never enjoyed the same, full freedom to engage in licensing that Universities have.

What is the current state of technology transfer? What battles lie ahead during the second half of the Biden Administration.

Materials*

Three Letters Summarize the March-In/ Compulsory Licensing Debate

The Bayh-Dole System Just Keeps Rollin’ Along – Despite Attempts to Throw it Off Track

Misusing March-in Rights for Price Control: A Dagger to the Heart of Small Companies

* A Note on Materials: We apply for MCLE, which requires substantive writing on the topic covered. The materials provided below, often published by IPWatchdog.com authors and contributors, relate to the topic but are not intended to pigeon-hole guest speakers in any way. They are hopefully informative, and the articles we select have to date always been sufficient to satisfy MCLE authorities.